MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Knight Therapeutics Company Profile (CVE:GUD)

Consensus Ratings for Knight Therapeutics (CVE:GUD) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: C$6.50

Analysts' Ratings History for Knight Therapeutics (CVE:GUD)
Show:
DateFirmActionRatingPrice TargetActions
3/6/2015MackieInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/2/2015LB SecuritiesReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/24/2014LB SecuritiesReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2014LB SecuritiesInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2014NBFInitiated CoverageOutperformC$6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2014National Bank FinancialInitiated CoverageOutperformC$6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2013 forward)